IP Library Granted Patent US 7,682,831
Granted Patent B2
US 7,682,831 · App. 10/536,186 · Granted Mar 23, 2010

Method of measuring lipid in specific lipoprotein

Assignee: Sekisui Medical Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,682,831
App. No.
10/536,186
Granted
Mar 23, 2010
Kind
B2
Abstract

A method of measuring a lipid in a specific lipoprotein characterized by using a polycyclic polyoxyalkylene derivative at least in the step of determining the specificity of the measurement of the target lipid.

Claims (26)

1. A method for assaying HDL cholesterol in a sample, comprising:

determining the specificity of an assay for HDL cholesterol, and

assaying HDL cholesterol using said assay;

wherein a mixture of a plurality of polycyclic polyoxyalkylene derivatives is employed at least in the specificity determining step, said mixture having an HLB of 14.1 to 18, and

wherein the polycyclic polyoxyalkylene derivatives are nonionic surfactants selected from the group consisting of polyoxyalkylene polycyclic phenyl ether, polyoxyethylene tribenzylphenyl ether, polyoxyalkylene polystyrylphenyl ether, polyoxyalkylene phenylphenol ether, polyoxyalkylene polystyrylphenyl ether condensate, polyoxyalkylene alkylphenyl ether condensate, polyoxyalkylene styrylated phenyl ether, and polyoxyalkylene allylphenyl ether.

2. The method of claim 1 , wherein said mixture has an HLB of 14.3 to 18.

3. The method of claim 1 , wherein said mixture is in solution form.

4. A method for assaying HDL cholesterol in a sample, comprising:

determining the specificity of an assay for HDL cholesterol, and

assaying HDL cholesterol using said assay;

wherein at least one polycyclic polyoxyalkylene derivative having an HLB of 14.1 to 18 and being selected from the group consisting of polyoxyalkylene polycyclic phenyl ether, polyoxyethylene tribenzylphenyl ether, polyoxyalkylene polystyrylphenyl ether; polyoxyalkylene phenylphenol ether, polyoxyalkylene polystyrylphenyl ether condensate, polyoxyalkylene alkylphenyl ether condensate, polyoxyalkylene styrylated phenyl ether, and polyoxyalkylene allylphenyl ether is employed at least in the specificity determining step.

5. The method of claim 4 , wherein said polycyclic polyoxyalkylene derivative has an HLB of 14.3 to 18.

6. The method in accordance with claim 4 , wherein the polycyclic polyoxyalkylene derivative is in a solution form.

7. A method for determining the amount of HDL cholesterol in a sample, comprising:

determining the specificity of an assay for HDL cholesterol by pretreating lipids other than HDL cholesterol in a biological sample to obtain a pretreated reaction mixture containing HDL cholesterol,

reacting the HDL cholesterol in said pretreated reaction mixture with an enzyme that releases cholesterol from said HDL cholesterol, and

assaying the cholesterol,

thereby determining the amount of HDL cholesterol in said biological sample;

wherein at least the determining the specificity of the assay is performed in the presence of at least one nonionic polycyclic polyoxyalkylene surfactant having an HLB of 14.1 to 18 selected from the group consisting of polyoxyalkylene polycyclic phenyl ether, polyoxyethylene tribenzylphenyl ether, polyoxyalkylene polystyrylphenyl ether, polyoxyalkylene phenylphenol ether, polyoxyalkylene polystyrylphenyl ether condensate, polyoxyalkylene alkylphenyl ether condensate, polyoxyalkylene styrylated phenyl ether, and polyoxyalkylene allylphenyl ether.

8. The method of claim 7 , wherein a mixture of a plurality of the polycyclic polyoxyalkylene surfactants is employed at least in the specificity determining step, said mixture having an HLB of 14.1 to 18.

9. The method of claim 7 , wherein said polycyclic polyoxyalkylene surfactant is in a solution form.

10. The method of claim 7 , wherein said biological sample is blood, serum or plasma.

11. The method of claim 7 , wherein said pretreated reaction mixture containing HDL cholesterol is produced without centrifugation of said biological sample.

12. The method of claim 7 , wherein said enzyme that releases cholesterol from HDL cholesterol is an esterase.

13. The method of claim 12 , wherein said esterase is employed in combination with an enzyme other than the esterase, a coenzyme, or a color coupler to assay cholesterol.

14. The method of claim 13 , wherein said HDL cholesterol is assayed by measuring the amount of change in absorbance at 37° C. at secondary wavelength 700 nm/primary wavelength 600 nm.

Assignments (2)
CHANGE OF NAME Recorded Feb 3, 2010
From: DAIICHI PURE CHEMICALS CO., LTD.
To: SEKISUI MEDICAL CO., LTD.
Reel/Frame 023889/0246 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 30, 2005
From: YAMAMOTO, SHOKO; YAMAMOTO, MITSUAKI; NAKANISHI, KAZUO; SAITO, KAZUNORI
To: DAIICHI PURE CHEMICALS CO., LTD.
Reel/Frame 016934/0227 →
Priority Claims (2)
JP 2002-343979 · Nov 27, 2002 · national
JP 2002-346115 · Nov 28, 2002 · national
Continuity (1)
Related Publication 20060014207A1 · Jan 19, 2006